AI-Generated Summary

Viva Biotech has been recognized with Frost & Sullivan's 2025 APAC Technology Innovation Leadership award for its integrated intelligent drug discovery platforms. The company is lauded for pioneering AI-driven systems that combine predictive modeling, physics-based simulations, and generative AI with wet lab validation. These platforms significantly accelerate drug development timelines, reduce costs, and enhance success rates for global pharmaceutical clients.

In a nutshell

This recognition underscores the critical role of AI in transforming early-stage drug discovery, offering pharmaceutical professionals and investors a glimpse into future R&D efficiencies. It highlights how integrated AI platforms are becoming essential for accelerating therapeutic innovation and addressing challenging targets across the healthcare landscape.

Source: PR Newswire UK